CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SagaMedica has developed SagaPro+, a natural product aimed at alleviating overactive bladder symptoms. This innovative solution, derived from Angelica archangelica, offers a safe alternative to existing treatments with no adverse effects.
Overactive bladder (OAB) is an emerging condition that significantly impacts the quality of life and daily routine of millions of people.
It is characterized by urinary urgency, increased urinary frequency and nocturia. OAB is extremely frequent, affecting more than 500 million people worldwide and its prevalence is expected to increase by 9,2% by 2018.
Despite being a widely spread affection, currently there is no effective treatment in the market, and the ones available are associated to adver…
SAGAMEDICA - HEILSUJURTIR EHF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
